Literature DB >> 29064972

Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.

.   

Abstract

Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use. In addition, after the device is removed, the return of fertility is rapid (1, 2). The purpose of this Practice Bulletin is to provide information for appropriate patient selection and evidence-based recommendations for LARC initiation and management. The management of clinical challenges associated with LARC use is beyond the scope of this document and is addressed in Committee Opinion No. 672, Clinical Challenges of Long-Acting Reversible Contraceptive Methods (3).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29064972     DOI: 10.1097/AOG.0000000000002400

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  32 in total

1.  Utilization of Long-Acting Reversible Contraceptives in the United States After vs Before the 2016 US Presidential Election.

Authors:  Lydia E Pace; Stacie B Dusetzina; Mara E Murray Horwitz; Nancy L Keating
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

2.  Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.

Authors:  Colleen P Judge-Golden; Harold C Wiesenfeld; Beatrice A Chen; Sonya Borrero
Journal:  J Womens Health (Larchmt)       Date:  2020-07-13       Impact factor: 2.681

3.  The Teen Access and Quality Initiative: Improving Adolescent Reproductive Health Best Practices in Publicly Funded Health Centers.

Authors:  Anna W Brittain; Heather D Tevendale; Trisha Mueller; Aniket D Kulkarni; Dawn Middleton; Michela L B Garrison; Mary R Read-Wahidi; Emilia H Koumans
Journal:  J Community Health       Date:  2020-06

4.  Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.

Authors:  Anupama Kotha; Beatrice A Chen; Lauren Lewis; Shannon Dunn; Katherine P Himes; Elizabeth E Krans
Journal:  Contraception       Date:  2018-08-13       Impact factor: 3.375

Review 5.  Public Health Implications of Very Preterm Birth.

Authors:  Wanda D Barfield
Journal:  Clin Perinatol       Date:  2018-09       Impact factor: 3.430

6.  Meeting Women's Requests for Intrauterine Device and Contraceptive Implant Discontinuation: An Exploratory Survey of Physicians.

Authors:  Bliss Kaneshiro; ZoeAnn Kon; Mary Tschann; Amanda Williams; Kasey Kajiwara; Reni Soon
Journal:  Hawaii J Health Soc Welf       Date:  2020-10-01

7.  Highly-Effective Contraception Use More Likely Among Native Hawaiian Women than Non-Native Hawaiian Women at Title X Clinics in Hawai'i.

Authors:  Chelsea Yin; Scott Harvey; Jennifer Elia; Bliss Kaneshiro; Donald Hayes; Reni Soon
Journal:  Hawaii J Health Soc Welf       Date:  2020-01

8.  Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis.

Authors:  Sarah H Averbach; Yokabed Ermias; Gary Jeng; Kathryn M Curtis; Maura K Whiteman; Erin Berry-Bibee; Denise J Jamieson; Polly A Marchbanks; Naomi K Tepper; Tara C Jatlaoui
Journal:  Am J Obstet Gynecol       Date:  2020-03-03       Impact factor: 8.661

9.  Placement of Levonorgestrel Intrauterine Device at the Time of Cesarean Delivery and the Effect on Breastfeeding Duration.

Authors:  Erika E Levi; Molly K Findley; Karina Avila; Amy G Bryant
Journal:  Breastfeed Med       Date:  2018-10-30       Impact factor: 1.817

10.  Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.

Authors:  Tara C Jatlaoui; Maura K Whiteman; Gary Jeng; Naomi K Tepper; Erin Berry-Bibee; Denise J Jamieson; Polly A Marchbanks; Kathryn M Curtis
Journal:  Obstet Gynecol       Date:  2018-10       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.